BioHarvest Sciences Inc.

BioHarvest Sciences Inc.

NNASDAQ:BHST
1.38
USD
-0.12
(-8.31%)

Share Statistics

As of June 30, 2026, BioHarvest Sciences Inc. has 22.67M shares outstanding.

Shares Outstanding22.67M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 1.69, and the price-to-book ratio stands at 3.28.

PS Ratio1.69
PB Ratio3.28
P/TBV Ratio3.28
P/FCF Ratio-9.54
P/OCF Ratio-7.03

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 1.81 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

EV / Sales1.81

Financial Position

As of June 30, 2026, BioHarvest Sciences Inc. maintains a current ratio of 2.24, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 79.41, indicating elevated leverage, while an interest coverage ratio of -2.27 demonstrates limited ability to service its debt obligations.

Current Ratio2.24
Quick Ratio1.75
Debt / Equity79.41
Debt / EBITDA-3.38
Interest Coverage-2.27

Financial Efficiency

Over the twelve months ended June 30, 2026, BioHarvest Sciences Inc. posted a negative return on equity (ROE) of -283.38, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -30.60, reflecting losses generated across the asset base. Inventory turnover of 2.94 indicates how many times BioHarvest Sciences Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-283.38
Return on Assets (ROA)-30.60
Inventory Turnover2.94

Stock Price Statistics

USD

As of the close on November 16, 2026, BioHarvest Sciences Inc.'s stock has declined approximately 80.91% over the past 52 weeks. The 50-day moving average sits at 1.63, while the 200-day moving average is 3.05.

52-Week Price Change-80.91%
50-Day Moving Average1.63
200-Day Moving Average3.05

Margins

Over the twelve months ended June 30, 2026, BioHarvest Sciences Inc. posted a gross margin of 58.95, reflecting its pricing power and cost economics. The operating margin of -17.99 and net profit margin of -31.21 provide insight into operational efficiency.

Gross Margin58.95
Operating Margin-17.99
Pretax Margin-30.94
Profit Margin-31.21
EBITDA Margin-13.09

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -10.48: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -35.73, meaning BioHarvest Sciences Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-35.73
FCF Yield-10.48

Stock Splits

BioHarvest Sciences Inc.'s most recent stock split took place on June 3, 2024 with a 35:1 split ratio.

Last Split Date6/3/2024
Split Ratio35:1

Scores

As of June 30, 2026, BioHarvest Sciences Inc. has an Altman Z-Score of -1.30, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-1.30